Practical Aspect of Intervention in Vascular Anomalies in Children

Josée Dubois; Laurent Garel

doi:10.1055/s-2002-25141

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2002; 19(1): 073-088
DOI: 10.1055/s-2002-25141

Practical Aspect of Intervention in Vascular Anomalies in Children

Josée Dubois, Laurent Garel

Université de Montréal, Hôpital Sainte-Justine, Montréal, Québec, Canada

Abstract

ABSTRACT

The authors describe the treatment of various vascular anomalies in children. Vascular tumors such as hemangiomas and angiosarcomas are discussed. Vascular malformations such as lymphatic malformations, arteriovenous malformations, and various venous abnormalities are detailed.

KEYWORD

Vascular malformations - catheter angiography - pediatric angiography

Volltext

Referenzen

REFERENCES

1 Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med . 1995; 333 1757-1763
2 Takabashi K, Mulliken J B, Kozakewich H, Rogers R A, Folkman J, Ezekowitz R A. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest . 1994; 93 2357-2364
3 Vikkula M, Boon L M, Mulliken J B, Olsew B R. Molecular basis of vascular anomalies. Trends Cardiovasc Med . 1998; 8 281-292
4 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg . 1982; 69 412-422
5 Enjolras O, Mulliken J B. Vascular tumors and vascular malformations (new issues). Adv Dermatol . 1998; 13 375-423
6 Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol . 1997; 24 701-710
7 Glowacki J, Mulliken J B. Mast cells in hemangiomas and vascular malformations. Pediatrics . 1982; 70 48-51
8 Pollman M J, Naumovski L, Gibbons G H. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β₁ on endothelial cells versus smooth muscle cells. Circulation . 1999; 99 2019-2026
9 Razon M J, Kraling B M, Mulliken J B, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation . 1998; 5 189-195
10 Arbiser J L. Angiogenesis and the skin: a primer. J Am Acad Dermatol . 1996; 34 486-497
11 Enjolras O. Vascular tumors and vascular malformations: are we at the dawn of a better knowledge?. Pediatr Dermatol . 1999; 16 238-241
12 Enjolras O, Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol . 1997; 14 173-179
13 Frieden I J, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol . 1996; 132 307-311
14 Sarkar M, Mulliken J B, Kozakewich H PW. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg . 1997; 100 1377-1386
15 Enjolras O, Wassef M, Mazoyer E. Infants with Kasabach-Merritt syndrome do not have ``true hemangiomas''. J Pediatr . 1997; 130 631-640
16 Daller J A, Bueno J, Gutierrez J. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg . 1999; 34 98-106
17 Enjolras O, Mulliken J B, Wassef M. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol . 2000; 42 225-235
18 Selby D M, Stocker J T, Ishak K G. Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study of 10 cases. Pediatr Pathol . 1992; 12 485-498
19 Awan S, Davenport M, Portmann B. Angiosarcoma of the liver in children. J Pediatr Surg . 1996; 31 1729-1732
20 Boon L M, Brouillard P, Irrthum A. A gene for inherited cutaneous venous anomalies (``glomangiomas'') localizes to chromosome 1p21-22. Am J Hum Genet . 1999; 65 125-133
21 Blei F, Walter J, Orlow S J. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol . 1998; 134 718-722
22 Enjolras O, Ciabrini D, Mazoyer E, Lauriane C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol . 1997; 36 219-225
23 Gallagher P G, Mahoney M J, Gosche J R. Cystic hygroma in the fetus and newborn. Semin Perinatol . 1999; 23 341-356
24 Dubois J, Patriquin H B, Garel L. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol . 1998; 171 247-252
25 Dubois J, Garel L, Grignon A. Imaging of hemangiomas and vascular malformations in children. Acad Radiol . 1998; 5 390-400
26 Burrows P E, Laor T, Paltiel H. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin . 1998; 16 455-488
27 Barnes P D, Burrows P E, Hoffer F A, Mulliken J B. Hemangiomas and vascular malformations of the head and neck: MR characterization [letter]. AJNR Am J Neuroradiol . 1994; 15 193-195
28 Baker L L, Dillon W P, Hieshima G B. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol . 1993; 14 307-314
29 Huston III J, Forbes G S, Ruefenacht D A. Magnetic resonance imaging of facial vascular anomalies. Mayo Clin Proc . 1992; 67 739-747
30 Hoffer F A. Facial vascular anomalies: clarity with magnetic resonance imaging and biologic classification. Mayo Clin Proc . 1992; 67 807-809
31 Frieden I J. Management of hemangiomas. Special symposium. Pediatr Dermatol . 1997; 14 57-83
32 Mulliken J B, Boon L M, Takahashi K. Pharmacologic therapy for endangering hemangiomas. Curr Opin Dermatol . 1995; 2 109-113
33 Drolet B A, Esterly N B, Frieden I J. Hemangiomas in children. Prim Care . 1999; 341 173-181
34 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med . 1992; 326 1456-1463
35 Barlow C F, Priebe C J, Mulliken J B. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr . 1998; 132 527-530
36 Dubois J, Hershon L, Carmant L, Bélanger S, Leclerc J M, David M. Toxicity profile of interferon alfa-2b in children: a prospective evaluation. J Pediatr . 1999; 135 782-785
37 Burrows P E. Variations in the vascular supply to infantile hepatic hemangioendotheliomas. Radiology . 1991; 181 631-632
38 Upton J, Coombs C J, Mulliken J B, Burrows P E, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am] . 1999; 24 1019-1035
39 Yakes W F, Luethke J M, Parker S H. Ethanol embolization of vascular malformations. Radiographics . 1990; 19 787-796
40 Dubois J, Sebag G H, De Prost Y, Teillac D, Chrétien B, Brunelle F. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology . 1991; 180 195-198
41 DeLorimier A A. Sclerotherapy for venous malformations. J Pediatr Surg . 1995; 30 188-194
42 Berenguer B, Burrows P E, Zurakowski D, Mulliken J B. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg . 1999; 104 1-11
43 O'Donovan J C, Donaldson J S, Morello F P, Pensler J M, Vogelzang R L, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol . 1997; 169 723-729
44 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations in the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg . 1997; 31 145-150
45 Hancock B J, St-Vil D, Di Lorenzo M, Blanchard H. Complications of lymphangiomas in children. Pediatr Surg . 1992; 27 220-226
46 Dickerhoff R, Bode V U. Cyclophosphamide in non-resectable cystic hygroma. Lancet . 1990; 335 1474-1475
47 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg . 1995; 30 1282-1287
48 Okada A, Kubota A, Fukyzama M. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg . 1992; 27 440-443
49 Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg . 1995; 30 1159-1160
50 Ogita S, Tsuto T, Nakamura K. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg . 1994; 29 784-785
51 Farmand M, Kuttenberger J J. A new therapeutic concept for the treatment of cystic hygroma. Oral Surg Oral Med Oral Pathol . 1995; 81 389-395
52 Dubois J, Garel L, Abela A. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology . 1997; 204 651-654
53 Castanon M, Margarit J, Carrasco R, Vancells M, Albert A, Morales L. Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant. J Pediatr Surg . 1999; 34 1276-1279.
54 Gutierrez San Roman C, Barrios J, Lluna J. Treatment of cervical lymphangioma using fibrin adhesive. Eur J Pediatr Surg . 1993; 3 356-358
55 Greinwald J H, Burke D K, Sato Y. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg . 1999; 121 381-387
56 Herbreteau D, Riche M C, Enjolras O. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol . 1993; 12 34-49
57 Han M H, Seong S O, Kim H D, Chang K H, Yeon K M, Han M C. Craniofacial arteriovenous malformation: preoperative embolization with direct puncture and injection of n-butyl cyanoacrylate. Radiology . 1999; 211 661-666
58 Kohout M P, Hansen M, Pribaz J J, Mulliken J B. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg . 1998; 102 643-654
59 Beek F J, ten Broek W F, van Schaik P J, Mali W P. Transvenous embolisation of an arteriovenous malformation of the mandible via a femoral approach. Pediatr Radiol . 1997; 27 855-857
60 Yakes W F, Rossi P, Odink H. How I do it: arteriovenous malformation management. Cardiovasc Intervent Radiol . 1996; 19 65-71
61 Yakes W F, Krauth L, Ecklund J. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery. . 1997; 40 1145-1154
62 Yakes W F, Luethke J M, Merland J J. Ethanol embolization of arteriovenous fistulas: a primary mode of therapy. J Vasc Interv Radiol . 1990; 1 89-96
63 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg . 1995; 80 415-417
64 Chen M T, Horng S Y, Yeong E K, Pan Q D. Treatment of high-flow vascular malformations in the head and neck with arterial ligation followed by sclerotherapy. Ann Plast Surg . 1996; 36 147
65 Svendsen P A, Wikholm G, Fogdestam I, Anniko M, Mendel L. Direct puncture of large arteriovenous malformations in head and neck for embolization and subsequent reconstructive surgery. Scand J Plast Reconstr Surg Hand Surg . 1994; 28 131
66 Coldwell D M, Stokes K R, Yakes W F. Embolotherapy: agents, clinical applications, and techniques. Radiographics . 1994; 14 623-643
67 Dubois J. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol . 1999; 29 879-893